当前位置: 首页 > 详情页

Tenuigenin protects cultured hippocampal neurons against methylglyoxal-induced neurotoxicity

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [a]Department of Traditional Chinese Medicine, Xuanwu Hospital of Capital Medical University, Beijing 100053, PR China [b]Department of Pharmacology, Xuanwu Hospital of Capital Medical University, Beijing 100053, PR China
出处:
ISSN:

关键词: Tenuigenin Methylglyoxal Hippocampal neurons Apoptosis Oxidative stress

摘要:
Methylglyoxal is a metabolite of glucose. Since serum methylglyoxal level is increased in diabetic patients, methylglyoxal is implicated in diabetic complications such as cognitive impairment. This study aimed to evaluate the effects of tenuigenin, an active component of roots of Polygala tenuifolia Willdenow, on methylglyoxal-induced cell injury in a primary culture of rat hippocampal neurons. MTT and Hoechst 33342 staining, together with flow cytometric analysis using annexin-V and propidium (PI) label, indicated that tenuigenin pretreatment attenuated methylglyoxal -induced apoptotic cell death in primary cultured hippocampal neurons, showing a dose-dependent pattern. Furthermore, 2, 7-dichlorodihydrofluorescein diacetate was used to detect the level of intracellular reactive oxygen species. Tenuigenin decreased the elevated reactive oxygen species induced by methylglyoxal. In addition, tenuigenin inhibited activation of caspase-3 and reversed down-regulation of the ratio of Bcl-2/Bax, both of which were induced by methylglyoxal stimulation. The results suggest that tenuigenin displays antiapoptotic and antioxidative activity in hippocampal neurons due to scavenging of intracellular reactive oxygen species, regulating Bcl-2 family and suppressing caspase-3 activity induced by methylglyoxal. which might explain at least in part the beneficial effects of tenuigenin against degenerative disorders involving diabetic cognitive impairment. (C) 2010 Elsevier B.V. All rights reserved.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2009]版:
大类 | 3 区 医学
小类 | 3 区 药学
最新[2023]版:
大类 | 3 区 医学
小类 | 2 区 药学
JCR分区:
出版当年[2008]版:
Q2 PHARMACOLOGY & PHARMACY
最新[2023]版:
Q1 PHARMACOLOGY & PHARMACY

影响因子: 最新[2023版] 最新五年平均 出版当年[2008版] 出版当年五年平均 出版前一年[2007版] 出版后一年[2009版]

第一作者:
第一作者机构: [a]Department of Traditional Chinese Medicine, Xuanwu Hospital of Capital Medical University, Beijing 100053, PR China [b]Department of Pharmacology, Xuanwu Hospital of Capital Medical University, Beijing 100053, PR China
共同第一作者:
通讯作者:
通讯机构: [*]No. 45, Chang-Chun Street, Beijing 100053, PR China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院